Company Search

Privatization of major medical laboratories from the National Hospital Service (NHS) in Britain has led to a dramatic decline in service quality, according to a "Transforming Pathology, the Serco way," a recent report from UK-based researchers Corporate Watch. Read More

A group of 13 anti-nuclear activists occupied the European headquarters of US arms manufacturer Lockheed Martin,in Brussels, in protest against the company's close links with the Bush government, and specifically its production of nuclear weapons and weapons ued in the war against Iraq. Read More

All data on completed medical experiments are to be made available to the general public by GlaxoSmithKline, the biggest UK pharmaceutical company. The announcement is a major win for the AllTrials campaign mounted by healthcare activists as well as researchers that has gathered widespread support. Read More

Ranbaxy, a subsidiary of Japanese pharmaceutical company Daiichi Sankyo, has paid a $500 million fine and pled guilty to selling adulterated drugs manufactured in India. The settlement comes 16 months after the company signed an agreement with U.S. authorities to change its ways. Read More

Myriad Genetics has lost its right to be the exclusive U.S. commercial provider of genetic screening tests for breast cancer or ovarian cancer. The American Civil Liberties Union (ACLU), which sued the company, claimed that the patent would limit scientific research as well as health care options for women. Read More

GlaxoSmithKline (GSK) has been accused of bribing doctors in China in order to boost sales. Chinese government officials say they have uncovered evidence of a bribery scheme involving 700 travel agencies who were used to funnel as much as three billion yuan ($480 million) in payments. Read More

Bayer, the German pharmaceutical giant, is in hot water after CEO Marijn Dekkers told a Financial Times conference that the company designed medicines "for western patients who can afford it" not for the "Indian market." The company has been critical of the Indian governments efforts to make cheap generic drugs available locally. Read More

Three major pharmaceutical companies - AstraZeneca, Johnson & Johnson and Pfizer - have recently delayed or canceled clinical trials for testing tuberculosis (TB) drugs in India and South Africa. Activists say this is symbolic of a trend by Big Pharma to abandon research into diseases that affect poor people. Read More

Gilead Sciences of San Francisco is under investigation by the U.S. Senate Finance Committee for charging $84,000 for a 12 week course of a new drug to treat hepatitis C. Gilead sells the exact same course for $900 in poor countries like Egypt and India. Read More

A vast tree planting project in the Batéké plateau of the Republic of the Congo, near the border with Gabon, funded by fossil fuel company TotalEnergies to offset company greenhouse gas emissions, has displaced local communities from using their traditional lands. Read More